Literature DB >> 12637313

Extending polymerization time of polymethylmethacrylate cement in percutaneous vertebroplasty with ice bath cooling.

Ram Chavali1, Rick Resijek, Steven K Knight, In Sup Choi.   

Abstract

Currently available preparations of polymethylmethacrylate (PMMA) cement for percutaneous vertebroplasty have injectability times of 4-15 minutes. The potential for early polymerization requires procedures to be performed as fast as possible, sometimes with suboptimal results and waste of the cement. By cooling the PMMA mixture in an iced bath of sodium chloride solution, we can extend its injectability to over 2 hours and use one kit for the controlled treatment of multiple levels with successive needle placements. We have been using this technique since mid-1998, treating more than 600 vertebral bodies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12637313      PMCID: PMC7973629     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  4 in total

Review 1.  Percutaneous vertebroplasty: a developing standard of care for vertebral compression fractures.

Authors:  J M Mathis; J D Barr; S M Belkoff; M S Barr; M E Jensen; H Deramond
Journal:  AJNR Am J Neuroradiol       Date:  2001-02       Impact factor: 3.825

2.  The effect of monomer-to-powder ratio on the material properties of cranioplastic.

Authors:  L E Jasper; H Deramond; J M Mathis; S M Belkoff
Journal:  Bone       Date:  1999-08       Impact factor: 4.398

3.  Effect of increasing temperature on the properties of four bone cements.

Authors:  M L Parks; H A Walsh; E A Salvati; S Li
Journal:  Clin Orthop Relat Res       Date:  1998-10       Impact factor: 4.176

4.  Letter: Effect of operating-theatre temperatures on the setting-times of acrylic cements for use in orthopaedic surgery.

Authors:  G P Pearson; D F Jones; V Wright
Journal:  Lancet       Date:  1975-07-26       Impact factor: 79.321

  4 in total
  13 in total

1.  Retrospective review of procedural parameters and outcomes of percutaneous vertebroplasty in 673 patients.

Authors:  Benny S Kim; Barbara Hum; Jung Cheol Park; In Sup Choi
Journal:  Interv Neuroradiol       Date:  2014-10-17       Impact factor: 1.610

2.  Vertebroplasty and balloon kyphoplasty in osteoporosis: friends or foes?

Authors:  Gemma Marcucci; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2009-09

3.  A new cannula to ease cement injection during vertebroplasty.

Authors:  G Baroud; T Steffen
Journal:  Eur Spine J       Date:  2005-01-26       Impact factor: 3.134

4.  Vertebroplasty in the treatment of spine disease.

Authors:  G Ambrosanio; A Lavanga; P Vassallo; R Izzo; A A Diano; M Muto
Journal:  Interv Neuroradiol       Date:  2006-02-10       Impact factor: 1.610

5.  Balloon kyphoplasty for acute osteoporotic compression fractures.

Authors:  T Yang; S Liu; X Lv; X Wu
Journal:  Interv Neuroradiol       Date:  2010-03-25       Impact factor: 1.610

6.  Kyphoplasty and vertebroplasty in the management of osteoporosis with subsequent vertebral compression fractures.

Authors:  Gemma Marcucci; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2010-01

7.  Vertebroplasty and kyphoplasty.

Authors:  Vincenzo Denaro; Umile Giuseppe Longo; Nicola Maffulli; Luca Denaro
Journal:  Clin Cases Miner Bone Metab       Date:  2009-05

Review 8.  [Percutaneous vertebroplasty (pv): indications, contraindications, and technique].

Authors:  R T Hoffmann; T F Jakobs; A Wallnöfer; M F Reiser; T K Helmberger
Journal:  Radiologe       Date:  2003-09       Impact factor: 0.635

9.  CT-guided percutaneous vertebroplasty: personal experience in the treatment of osteoporotic fractures and dorsolumbar metastases.

Authors:  R Caudana; L Renzi Brivio; L Ventura; E Aitini; U Rozzanigo; G Barai
Journal:  Radiol Med       Date:  2008-02-25       Impact factor: 3.469

10.  Evaluation of a novel radiopacifiying agent on the physical properties of surgical spineplex.

Authors:  D O'Brien; D Boyd; S Madigan; S Murphy
Journal:  J Mater Sci Mater Med       Date:  2009-08-18       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.